InGeneron and its partners have been conducting research for over ten years on the use of autologous adult stem cells in regenerative medicine. During this time, InGeneron’s team of scientists and clinicians have published more than 40 peer-reviewed studies in collaboration with renowned academic institutions such as M.D. Anderson Cancer Center and Tulane University. InGeneron is committed to drive incorporation of cell therapy into best practice standards through the development of innovative products that are safe, minimally invasive, easy to use, and cost effective. Therefore, all of InGeneron’s efforts are based on scientific rationale and best practice in research and development.